Gene set enrichment analysis (GSEA) results suggest that MRPL13 may participate in the development and progression of lung cancer by modulating key signaling pathways such as MYC targets, PI3K/AKT/mTOR signaling, oxidative phosphorylation, and the G2/M checkpoint (53). The gene discussed is MYC; the disease is lung cancer.